These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32856365)

  • 1. Stronger Together: Multivalent Phage Capsids Inhibit Virus Entry.
    Gallego I; Lostalé-Seijo I; Montenegro J
    Chembiochem; 2021 Feb; 22(3):478-480. PubMed ID: 32856365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein.
    White K; Esparza M; Liang J; Bhat P; Naidoo J; McGovern BL; Williams MAP; Alabi BR; Shay J; Niederstrasser H; Posner B; García-Sastre A; Ready J; Fontoura BMA
    J Med Chem; 2021 Aug; 64(15):10951-10966. PubMed ID: 34260245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals.
    Heldt FS; Frensing T; Pflugmacher A; Gröpler R; Peschel B; Reichl U
    PLoS Comput Biol; 2013; 9(11):e1003372. PubMed ID: 24278009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus.
    Adam L; Müller E; Ludwig K; Klenk S; Lauster D; Liese S; Herrmann A; Hackenberger CPR
    Bioconjug Chem; 2022 Jul; 33(7):1269-1278. PubMed ID: 35759354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive Flexible Sialylated Nanogels as Highly Potent Influenza A Virus Inhibitors.
    Bhatia S; Hilsch M; Cuellar-Camacho JL; Ludwig K; Nie C; Parshad B; Wallert M; Block S; Lauster D; Böttcher C; Herrmann A; Haag R
    Angew Chem Int Ed Engl; 2020 Jul; 59(30):12417-12422. PubMed ID: 32441859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
    Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
    Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus.
    Hussein AFA; Cheng H; Tundup S; Antanasijevic A; Varhegyi E; Perez J; AbdulRahman EM; Elenany MG; Helal S; Caffrey M; Peet N; Manicassamy B; Rong L
    Antiviral Res; 2020 May; 177():104782. PubMed ID: 32222293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
    Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
    ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes.
    Papp I; Sieben C; Sisson AL; Kostka J; Böttcher C; Ludwig K; Herrmann A; Haag R
    Chembiochem; 2011 Apr; 12(6):887-95. PubMed ID: 21384484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro methods for testing antiviral drugs.
    Rumlová M; Ruml T
    Biotechnol Adv; 2018; 36(3):557-576. PubMed ID: 29292156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.
    Kim M; Yim JH; Kim SY; Kim HS; Lee WG; Kim SJ; Kang PS; Lee CK
    Antiviral Res; 2012 Feb; 93(2):253-259. PubMed ID: 22197247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.
    Vanderlinden E; Vanstreels E; Boons E; ter Veer W; Huckriede A; Daelemans D; Van Lommel A; Rőth E; Sztaricskai F; Herczegh P; Naesens L
    J Virol; 2012 Sep; 86(17):9416-31. PubMed ID: 22740402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
    Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
    Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
    Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
    J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening.
    Weisshaar M; Cox R; Morehouse Z; Kyasa SK; Yan D; Oberacker P; Mao S; Golden JE; Lowen AC; Natchus MG; Plemper RK
    J Virol; 2016 Aug; 90(16):7368-7387. PubMed ID: 27252534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutinin Inhibitors are Potential Future Anti-Influenza Drugs for Mono- and Combination Therapies.
    Sriwilaijaroen N; Suzuki Y
    Methods Mol Biol; 2020; 2132():547-565. PubMed ID: 32306356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of traditional medicinal plant extracts with novel anti-influenza activity.
    Rajasekaran D; Palombo EA; Chia Yeo T; Lim Siok Ley D; Lee Tu C; Malherbe F; Grollo L
    PLoS One; 2013; 8(11):e79293. PubMed ID: 24312177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
    Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry.
    Lauster D; Klenk S; Ludwig K; Nojoumi S; Behren S; Adam L; Stadtmüller M; Saenger S; Zimmler S; Hönzke K; Yao L; Hoffmann U; Bardua M; Hamann A; Witzenrath M; Sander LE; Wolff T; Hocke AC; Hippenstiel S; De Carlo S; Neudecker J; Osterrieder K; Budisa N; Netz RR; Böttcher C; Liese S; Herrmann A; Hackenberger CPR
    Nat Nanotechnol; 2020 May; 15(5):373-379. PubMed ID: 32231271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.